- Home
- FLOC vs SUPN Comparison
FLOC vs SUPN Comparison
Compare FLOC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLOC
- SUPN
- Stock Information
- Founded
- FLOC 1996
- SUPN 2005
- Country
- FLOC United States
- SUPN United States
- Employees
- FLOC N/A
- SUPN N/A
- Industry
- FLOC Metal Fabrications
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- FLOC Industrials
- SUPN Health Care
- Exchange
- FLOC Nasdaq
- SUPN Nasdaq
- Market Cap
- FLOC 1.9B
- SUPN 1.8B
- IPO Year
- FLOC 2025
- SUPN 2012
- Fundamental
- Price
- FLOC $18.27
- SUPN $33.18
- Analyst Decision
- FLOC Strong Buy
- SUPN Hold
- Analyst Count
- FLOC 5
- SUPN 2
- Target Price
- FLOC $33.40
- SUPN $36.00
- AVG Volume (30 Days)
- FLOC 396.3K
- SUPN 790.6K
- Earning Date
- FLOC 08-06-2025
- SUPN 08-05-2025
- Dividend Yield
- FLOC 1.75%
- SUPN N/A
- EPS Growth
- FLOC N/A
- SUPN N/A
- EPS
- FLOC 2.69
- SUPN 1.11
- Revenue
- FLOC $660,916,000.00
- SUPN $667,997,000.00
- Revenue This Year
- FLOC $51.92
- SUPN N/A
- Revenue Next Year
- FLOC $11.23
- SUPN $12.02
- P/E Ratio
- FLOC $6.79
- SUPN $29.94
- Revenue Growth
- FLOC 156.58
- SUPN 11.82
- 52 Week Low
- FLOC $15.83
- SUPN $26.65
- 52 Week High
- FLOC $30.50
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- FLOC N/A
- SUPN 60.49
- Support Level
- FLOC N/A
- SUPN $31.35
- Resistance Level
- FLOC N/A
- SUPN $33.80
- Average True Range (ATR)
- FLOC 0.00
- SUPN 0.92
- MACD
- FLOC 0.00
- SUPN 0.16
- Stochastic Oscillator
- FLOC 0.00
- SUPN 79.12
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.